title: Prevention of veno-occlusive disease of the liver after bone marrow transplantation: heparin or no heparin?
authors.forename: J Y
authors.initials: JY
authors.lastname: Cahn
authors.forename: M
authors.initials: M
authors.lastname: Flesch
authors.forename: A
authors.initials: A
authors.lastname: Brion
authors.forename: E
authors.initials: E
authors.lastname: Deconinck
authors.forename: M F
authors.initials: MF
authors.lastname: Leconte Des Floris
authors.forename: L
authors.initials: L
authors.lastname: Voillat
authors.forename: E
authors.initials: E
authors.lastname: Plouvier
authors.forename: D
authors.initials: D
authors.lastname: Amsallem
authors.forename: P
authors.initials: P
authors.lastname: Tiberghien
authors.forename: T
authors.initials: T
authors.lastname: Fest
mesh_terms: D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D006493:Heparin / Q000627:therapeutic use*; D006504:Hepatic Veno-Occlusive Disease / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans
chemical_list: D006493:Heparin